Researchers at Queen’s University have found that current cancer trial efforts do not match the global burden of deaths from the disease. A new study led by Christopher Booth, Professor in the Department of Oncology and Department of Public Health Sciences and the Canada Research Chair in Populations Cancer Care, is taking a closer look at the number of randomized clinical trials conducted in high-income countries compared to low-income countries, and what this means in terms of the global fight against the disease. Dr. Booth’s international team of researchers included Bishal Gyawali, Assistant Professor, Department of Public Health Sciences and Clinical Fellow, Department of Oncology, and Nazik Hammad, Assistant Professor in the Department of Oncology, and head of the Global Health department.